Small Molecules in Neurodegeneration
- Publisher's listprice GBP 155.00
-
78 445 Ft (74 710 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 7 845 Ft off)
- Discounted price 70 601 Ft (67 239 Ft + 5% VAT)
78 445 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 12 March 2025
- ISBN 9781032857282
- Binding Hardback
- No. of pages286 pages
- Size 254x178 mm
- Weight 690 g
- Language English
- Illustrations 7 Illustrations, black & white; 9 Illustrations, color; 5 Halftones, color; 7 Line drawings, black & white; 4 Line drawings, color; 17 Tables, black & white 695
Categories
Short description:
Neurodegenerative diseases cast a long shadow over millions of lives, stealing memories, independence, and futures. This book investigates deep into the intricacies of small molecules, exploring their potential to unravel the mysteries of neurodegenerative diseases and pave the way for innovative therapeutic interventions.
MoreLong description:
Neurodegenerative diseases, like Alzheimer's, Parkinson's, and Huntington's, cast a long shadow over millions of lives, stealing memories, independence, and futures. The rising tide of these age-related disorders threatens to overwhelm healthcare systems worldwide, prompting an urgent search for effective treatments. While current options offer temporary relief, they fail to halt the relentless march of these devastating conditions. However, a beacon of hope shines at the intersection of cutting-edge neuroscience and the world of small molecules. These tiny chemical warriors, with their inherent advantages of cost-effectiveness, scalability, and diverse functionalities, are emerging as powerful weapons in the fight against neurodegeneration. This book stands as a testament to this increasing revolution. It investigates deep into the intricacies of small molecules, exploring their potential to unravel the mysteries of neurodegenerative diseases and pave the way for innovative therapeutic interventions.
Key Features:
- Provides a comprehensive and accessible overview of the emerging field of small molecules in neurodegenerative diseases.
- Bridges the gap in current literature by addressing the specific impact of small molecules on these devastating conditions.
- Offers an in-depth exploration of the various mechanisms by which small molecules can combat neurodegeneration.
- Serves as a valuable resource for a wide audience, from students to professionals in the field.
- Lays the foundation for a deeper understanding of neurodegenerative diseases and unlocks new avenues for the development of effective therapies.
Table of Contents:
Chapter 1. Introduction to Neurodegenerative Diseases. Chapter 2. Small molecules: An emerging therapeutic frontier. Chapter 3. Small molecules in multiple sclerosis: An update. Chapter 4. Andrographolide in Neurological Disorders: a detailed overview. Chapter 5. Natural Products as Neuroprotective Agents. Chapter 6. Medicinal Chemistry and the Design of Small Molecules. Chapter 7. Neurotrophic Factors and Small Molecule Mimetics. Chapter 8. Repurposed Drugs: Expanding the Therapeutic Resource. Chapter 9. Integrating Small Molecules into Multimodal Treatment Strategies. Chapter 10. Advances in Small Molecule Delivery Systems for the Treatment of Neurodegenerative Disease. Chapter 11. An Enigmatic role of Small Molecule Therapeutics in Neurodegeneration. Chapter 12. Bridging the Gap in Neurodegenerative Disease Therapy (NDT). Chapter 13. Ethical and Economic Considerations in Small Molecule Therapy.
More
